Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
The Journal of Rheumatology|August 28, 2007
Rituximab for refractory polymyositis: an open-label prospective studyChi Chiu Mok, Ling Yin Ho, Chi Hung To
Annals of the Rheumatic Diseases|May 17, 2012
Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control studyChi Chiu Mok, Ling Yin Ho, Lai Shan Fong, et al.
The Journal of Rheumatology|August 9, 2008
Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006Chi Chiu Mok, Chi Hung To, Ling Yin Ho, et al.
Clinical Rheumatology|January 27, 2010
Venous thromboembolism in southern Chinese patients with systemic lupus erythematosusChi Chiu Mok, Ling Yin Ho, Ka Lung Yu, et al.
Lupus|January 18, 2023
Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosusChi Chiu Mok, Yuen Kwan Chung, Carolyn Lee, et al.
Therapeutic Advances in Musculoskeletal Disease|June 2, 2022
Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patientsYuen Kwan Chung, Ling Yin Ho, Carolyn Lee, et al.
Medicine|June 25, 2013
Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort studyChi Chiu Mok, Pak To Chan, Ling Yin Ho, et al.
Inflammation|May 6, 2023
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Associated with Disease Activity and Risk of Incident Cardiovascular Disease in Patients with Systemic Lupus ErythematosusChi Chiu Mok, Ling Yin Ho, Kar Li Chan, et al.
Frontiers in Medicine|October 5, 2020
Trend of Survival of a Cohort of Chinese Patients With Systemic Lupus Erythematosus Over 25 YearsChi Chiu Mok, Ling Yin Ho, Kar Li Chan, et al.
Clinical Rheumatology|November 17, 2022
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapiesChi Chiu Mok, Ling Yin Ho, Sau Mei Tse, et al.
Pageof 17